At the time of writing, Galmed Pharmaceuticals Ltd [GLMD] stock is trading at $1.46, up 10.61%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The GLMD shares have gain 6.57% over the last week, with a monthly amount glided 8.96%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Galmed Pharmaceuticals Ltd [NASDAQ: GLMD] stock has seen the most recent analyst activity on May 22, 2020, when B. Riley FBR downgraded its rating to a Neutral and also revised its price target to $8 from $11. Previously, Craig Hallum started tracking the stock with Buy rating on February 04, 2020, and set its price target to $18. Canaccord Genuity started tracking the stock assigning a Buy rating. B. Riley FBR initiated its recommendation with a Buy and recommended $28 as its price target on December 12, 2018. Maxim Group reiterated a Buy rating for this stock on August 02, 2018, and downed its price target to $27. In a note dated July 13, 2018, Stifel initiated an Buy rating and provided a target price of $35 on this stock.
For the past year, the stock price of Galmed Pharmaceuticals Ltd fluctuated between $1.15 and $23.80. Galmed Pharmaceuticals Ltd [NASDAQ: GLMD] shares were valued at $1.46 at the most recent close of the market.
Analyzing the GLMD fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.41, Equity is -0.51 and Total Capital is -0.38.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.2700 points at the first support level, and at 1.0800 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.6700, and for the 2nd resistance point, it is at 1.8800.
Ratios To Look Out For
It is important to note that Galmed Pharmaceuticals Ltd [NASDAQ:GLMD] has a current ratio of 7.42. In addition, the Quick Ratio stands at 7.42 and the Cash Ratio stands at 2.14.